267
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Bibliometric Analysis of Global Trends in Remimazolam-Related Research Over the Past 15 Years: Compared with Propofol

, , , & ORCID Icon
Pages 2119-2135 | Received 09 Mar 2023, Accepted 30 May 2023, Published online: 20 Jul 2023

References

  • Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a Novel Ultra–short-acting benzodiazepine. Anesthesiology. 2007;107(1):60–66. doi:10.1097/01.anes.0000267503.85085.c0
  • Keam SJ. Remimazolam: first Approval. Drugs. 2020;80(6):625–633. doi:10.1007/s40265-020-01299-8
  • Chen Y, Jin Q, Fang H, et al. Analytic network process: academic insights and perspectives analysis. J Clean Prod. 2019;235:1276–1294. doi:10.1016/j.jclepro.2019.07.016
  • Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173–176. doi:10.1007/s40037-021-00695-4
  • Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724–728.
  • Aria M, Cuccurullo C. bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959–975. doi:10.1016/j.joi.2017.08.007
  • van Eck NJ, Waltman L. Software survey: vOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/s11192-009-0146-3
  • Chen C. Predictive effects of structural variation on citation counts. J Am Soc Inf Sci. 2012;63(3):431–449. doi:10.1002/asi.21694
  • Jones T, Huggett S, Kamalski J. Finding a way through the scientific literature: indexes and measures. World Neurosurg. 2011;76(1):36–38. doi:10.1016/j.wneu.2011.01.015
  • Upton RN, Somogyi AA, Martinez AM, Colvill J, Grant C. Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep. Br J Anaesth. 2010;105(6):798–809. doi:10.1093/bja/aeq260
  • Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83(5):984–992. doi:10.1016/j.gie.2015.08.062
  • Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36(9):1021–1027. doi:10.1002/phar.1806
  • Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274–283. doi:10.1213/ANE.0b013e31823f0c28
  • Rex DK, Bhandari R, Desta T, et al. A Phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427–437.e6. doi:10.1016/j.gie.2018.04.2351
  • Rex DK, Bhandari R, Lorch DG, Meyers M, Schippers F, Bernstein D. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53(1):94–101. doi:10.1016/j.dld.2020.10.039
  • Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137–146. doi:10.1016/j.chest.2018.09.015
  • Dou D, Feng Y, Jiang L. Efficiency and safety of remimazolam and midazolam in digestive endoscopic sedation: systematic review and meta-analysis. Dig Endosc. 2022;34(3):653. doi:10.1111/den.14219
  • Wang M, Zhao X, Yin P, Bao X, Tang H, Kang X. Profile of remimazolam in anesthesiology: a narrative review of clinical research progress. Drug Des Devel Ther. 2022;16:3431–3444. doi:10.2147/DDDT.S375957
  • Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594–4603.
  • Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol. 2021;12:690875. doi:10.3389/fphar.2021.690875
  • Park I, Cho M, Nam SW, Hwang JW, Do SH, Na HS. Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study. BMC Anesthesiol. 2022;22(1):237. doi:10.1186/s12871-022-01779-2
  • Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491–501. doi:10.1007/s00540-020-02776-w
  • Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34(4):543–553. doi:10.1007/s00540-020-02788-6
  • Zhou J, Leonowens C, Ivaturi VD, et al. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020;66:109899. doi:10.1016/j.jclinane.2020.109899
  • Tang Y, Yang X, Shu H, et al. Remimazolam besylate for sedation of postoperative patients in intensive care units: a Phase I, open label, dose-finding study. Chin Med J. 2022;135(17):2134–2136. doi:10.1097/CM9.0000000000002243
  • Tang Y, Yang X, Yu Y, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26(1):279. doi:10.1186/s13054-022-04168-w
  • Choi JY, Lee HS, Kim JY, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: a randomized non-inferiority trial. J Clin Anesth. 2022;82:110955. doi:10.1016/j.jclinane.2022.110955
  • Suzuki Y, Kawashima S, Makino H, Doi M, Nakajima Y. A comparison of remimazolam and propofol for postoperative nausea and vomiting: a propensity score-matched, observational, single-center cohort study. Korean J Anesthesiol. 2022;76:143–151. doi:10.4097/kja.22441
  • Mao Y, Guo J, Yuan J, Zhao E, Yang J. Quality of recovery after general anesthesia with remimazolam in patients’ undergoing urologic surgery: a randomized controlled trial comparing remimazolam with propofol. DDDT. 2022;16:1199–1209. doi:10.2147/DDDT.S359496
  • Lu C, Ren J, Guo X, Qian J. Effects of remimazolam combined with esketamine anesthesia on circulatory and respiratory function during painless gastroenteroscopy. Contrast Media Mol Imaging. 2022;2022:1079099. doi:10.1155/2022/1079099
  • Yi X, Xu W, Li A. The clinical application of remimazolam benzenesulfonate combined with esketamine intravenous anesthesia in endoscopic retrograde cholangiopancreatography. Biomed Res Int. 2022;2022:5628687. doi:10.1155/2022/5628687
  • Xu C, He L, Ren J, et al. Efficacy and safety of remimazolam besylate combined with alfentanil in painless gastroscopy: a randomized, single-blind, parallel controlled study. Contrast Media Mol Imaging. 2022;2022:7102293. doi:10.1155/2022/7102293
  • Dong SA, Guo Y, Liu SS, et al. A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures. J Clin Anesth. 2023;86:111077. doi:10.1016/j.jclinane.2023.111077
  • Stöhr T, Colin PJ, Ossig J, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127(3):415–423. doi:10.1016/j.bja.2021.05.027
  • Nakanishi T, Sento Y, Kamimura Y, Tsuji T, Kako E, Sobue K. Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis: a prospective, observational pilot study. BMC Anesthesiol. 2021;21(1):306. doi:10.1186/s12871-021-01530-3
  • Liu T, Lai T, Chen J, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: a randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021;9(5):e00851. doi:10.1002/prp2.851
  • Miyoshi H, Watanabe T, Kido K, et al. Remimazolam requires less vasopressor support during induction and maintenance of general anesthesia in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a retrospective analysis from a single center. Biomed Res Int. 2022;2022:6386606. doi:10.1155/2022/6386606
  • Tan Y, Ouyang W, Tang Y, Fang N, Fang C, Quan C. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 2022;37(3):576–583. doi:10.1111/jgh.15761
  • Ibrahim AE, Taraday JK, Kharasch ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology. 2001;95(5):1151–1159. doi:10.1097/00000542-200111000-00019
  • Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132(4):636–651. doi:10.1097/ALN.0000000000003103
  • Eisenried A, Schuettler J, Lerch M, Ihmsen H, Jeleazcov C. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020;132(4):652–666. doi:10.1097/ALN.0000000000003102
  • Horikoshi Y, Kuratani N, Tateno K, et al. Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy. Medicine. 2021;100(49):e28209. doi:10.1097/MD.0000000000028209
  • Petkus H, Willer BL, Tobias JD. Remimazolam in a pediatric patient with a suspected family history of malignant hyperthermia. J Med Cases. 2022;13(8):386–390. doi:10.14740/jmc3977
  • Yamadori Y, Yamagami Y, Matsumoto Y, et al. General anesthesia with remimazolam for a pediatric patient with MELAS and recurrent epilepsy: a case report. JA Clin Rep. 2022;8(1):75. doi:10.1186/s40981-022-00564-x
  • Yang X, Lin C, Chen S, Huang Y, Cheng Q, Yao Y. Remimazolam for the prevention of emergence delirium in children following tonsillectomy and adenoidectomy under sevoflurane anesthesia: a randomized controlled study. Drug Des Devel Ther. 2022;16:3413–3420. doi:10.2147/DDDT.S381611